-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The use of intravenous thrombolysis is related to the improvement of patients' clinical outcomes
.
Whether thrombolysis is associated with a decrease in the incidence of post-stroke dementia is unclear
Stroke
Recently, the heart blood vessels published a research article on the disease areas authoritative journal Stroke, researchers attempted to use observational studies to estimate whether after first ischemic stroke thrombolysis associated with a reduced incidence of dementia
.
The researchers included the first patients with ischemic stroke in the Ontario Stroke Registry who had not previously been diagnosed with dementia
.
The main outcome of the study was a dementia event determined by a validated diagnostic algorithm
diagnosis
From July 2003 to March 2013, researchers enrolled 7072 patients with ischemic stroke, including 3276 (46.
3%) women, with an average age of 71.
0 (SD 12.
8) years
.
Overall, 38.
It can be seen that thrombolytic therapy after the first ischemic stroke is independently associated with a decrease in the incidence of dementia
.
When assessing the risk/benefit of thrombolysis in patients with ischemic stroke, event dementia should be considered as a relevant outcome
Thrombolytic therapy after the first ischemic stroke is independently associated with a decrease in the incidence of dementia
Original source:
Joshua O.
